HORIZONHORIZON-MISS-2027-02-CANCER-03
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Határidő
2027. szeptember 21. · 415 nap van hátra
Max. támogatás
—
Támogatás-intenzitás
—
Régió
Országos
Kedvezményezettek
HORIZON Research and Innovation Actions
Hivatalos leírás
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes